Skip to content

Aclaris Therapeutics, Inc.: filings

Every Aclaris Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026381080001104659-26-092065
10-Q2026-05-07fiscal Q1 202638800001104659-26-057202
10-K2026-02-26fiscal FY 202540820001104659-26-020540
10-Q2025-11-06fiscal Q3 2025421240001104659-25-107788
10-Q2025-08-07fiscal Q2 2025451260001558370-25-010789
10-Q2025-05-08fiscal Q1 202545940001558370-25-006993
10-K2025-02-27fiscal FY 202447940001558370-25-001819
10-Q2024-11-06fiscal Q3 2024441250001558370-24-014646
10-Q2024-08-07fiscal Q2 2024431200001558370-24-011376
10-Q2024-05-07fiscal Q1 202443890001558370-24-007069
10-K2024-02-27fiscal FY 2023501260001558370-24-001753
10-Q2023-11-06fiscal Q3 2023471330001558370-23-017660
10-Q2023-08-07fiscal Q2 2023471290001558370-23-013491
10-Q2023-05-08fiscal Q1 202347960001558370-23-008382
10-K2023-02-23fiscal FY 2022501270001558370-23-001829
10-Q2022-11-08fiscal Q3 2022471330001558370-22-016738
10-Q2022-08-03fiscal Q2 2022471290001558370-22-011757
10-Q2022-05-10fiscal Q1 202247960001558370-22-007972
10-K2022-02-24fiscal FY 2021511280001558370-22-001838
10-Q2021-11-02fiscal Q3 2021431140001558370-21-013989
10-Q2021-08-05fiscal Q2 2021431110001558370-21-010389
10-Q2021-05-07fiscal Q1 202143880001558370-21-006362
10-K2021-02-25fiscal FY 2020471150001558370-21-001717
10-Q2020-11-04fiscal Q3 2020431140001558370-20-012488
10-Q2020-08-07fiscal Q2 2020421080001558370-20-009814
10-Q2020-05-07fiscal Q1 202042850001558370-20-005744
10-K2020-02-25fiscal FY 2019491150001558370-20-001325
10-Q2019-11-07fiscal Q3 2019451140001558370-19-010425
10-Q2019-08-08fiscal Q2 2019461120001558370-19-007745
10-Q2019-05-08fiscal Q1 201946890001558370-19-004494
10-K2019-03-18fiscal FY 2018491410001558370-19-002211
10-Q2018-11-06fiscal Q3 2018441110001558370-18-008658
10-Q2018-08-03fiscal Q2 2018441050001558370-18-006295
10-Q2018-05-08fiscal Q1 201841810001558370-18-004349
10-K2018-03-12fiscal FY 2017431190001558370-18-001866
10-Q2017-11-07fiscal Q3 201739930001558370-17-008320
10-Q2017-08-08fiscal Q2 201732820001558370-17-006211
10-Q2017-05-09fiscal Q1 201728580001558370-17-004000
10-K2017-03-15fiscal FY 2016311020001558370-17-001802
10-Q2016-11-03fiscal Q3 201629780001558370-16-009151
10-Q2016-08-11fiscal Q2 201629780001558370-16-007893
10-Q2016-05-11fiscal Q1 201629600001558370-16-005857
10-K2016-03-23fiscal FY 201528920001558370-16-004311
10-Q2015-12-03fiscal Q3 201527720001104659-15-082661

Inspect the source

Entity
Aclaris Therapeutics, Inc. / CIK 0001557746
Captured
2026-09-20T09:19:24.072Z
SEC response SHA-256
bd067eca359ab7483085dcfaa0c6599f7d43a04b28cd32e29ba3aeb93594e610

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001557746.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))